Osteoporosis - American Family Physician
Aug 15, 2020 - This collection features AFP content on osteoporosis and related issues, including calcium supplementation, fracture prevention, hip fracture, radiologic bone assessment, and vitamin D deficiency. This collection features AFP content on osteoporosis and related issues, including calcium...
- Overview
- Screening and Diagnosis
- Treatment
- Complications and Special Situations
- Editorials and Letters
- Improving Practice
- Patient Education, Self-Care
- Other AFP Content
American Family Physician : AFP By Topic
https://www.aafp.org/afp/topicModules/viewTopicModule.htm?topicModuleId=20
Screening for Osteoporosis to Prevent Fractures: Recommendation Statement - U.S. ...
Nov 15, 2018 - The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 years and older.
American Family Physician : U.S. Preventive Services Task Force
https://www.aafp.org/afp/2018/1115/od1.html
Denosumab No Better than Bisphosphonates for Preventing Fracture, and the Cost Is Much ...
Sep 15, 2020 - This meta-analysis found no evidence that the monoclonal antibody denosumab reduces the risk of fracture more than bisphosphonates.
American Family Physician : POEMs
https://www.aafp.org/afp/2020/0915/p375a.html
Fracture Prevention in Older Adults - Lown Right Care: Reducing Overuse and Underuse - ...
Mar 15, 2020 - A collaboration between AFP and the Lown Institute promotes a vision of delivering health care that is based on the evidence, balanced in its approach, and focused on the patient.
American Family Physician : Lown Right Care: Reducing Overuse and Underuse
https://www.aafp.org/afp/2020/0315/p370.html
Denosumab for Reducing Risk of Fractures in Postmenopausal Women - Medicine by the ...
May 1, 2019 - Denosumab appears to be effective in reducing the risk of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis. Treatment with denosumab does not increase the risk of cancer or death but might increase the risk of infection. However, more studies are required.
American Family Physician : Medicine by the Numbers
https://www.aafp.org/afp/2019/0501/od1.html
Abaloparatide (Tymlos) for Osteoporosis - STEPS - American Family Physician
Feb 15, 2019 - Abaloparatide is a safe and effective medication used to reduce the likelihood of vertebral and nonvertebral fractures in women at high risk. However, it is expensive and requires daily injections. It has not been evaluated for its effect on decreasing hip fractures.
American Family Physician : STEPS
https://www.aafp.org/afp/2019/0215/p260.html
Screening for Osteoporosis to Prevent Fractures - Putting Prevention into Practice - ...
Nov 15, 2018 - A 57-year-old postmenopausal woman comes to your clinic for a wellness visit. She has no significant medical problems. She broke her left forearm as a child by falling out of a tree but has had no other fractures. She currently smokes one pack of cigarettes per day, rarely drinks one ...
American Family Physician : Putting Prevention into Practice
https://www.aafp.org/afp/2018/1115/p593.html
Treatment of Low BMD and Osteoporosis to Prevent Fractures: Updated Guideline from the ...
Mar 1, 2018 - Osteoporosis, which most commonly occurs in the hip, spine, and wrist, puts persons at increased risk of fragility and fracture. The American College of Physicians (ACP) has updated its 2008 guideline to include new evidence regarding fracture prevention in adults with low bone mineral ...
American Family Physician : Practice Guidelines
https://www.aafp.org/afp/2018/0301/p352.html
The Female Athlete Triad: Recommendations for Management - Editorials - American Family...
Apr 15, 2018 - Family physicians should be familiar with recommendations regarding the female athlete triad, because prevention and early intervention can significantly reduce morbidity from this disorder.
American Family Physician : Editorials
https://www.aafp.org/afp/2018/0415/p499.html
Duration of Bisphosphonate Therapy - FPIN's Help Desk Answers - American Family Physician
Apr 1, 2018 - Oral bisphosphonates significantly reduce clinical fracture risk at four years in women with postmenopausal osteoporosis (T-score less than −2.5). Treatment beyond five years is associated with further reductions in fractures in women with persistent femoral neck T-scores less than −2.5.
American Family Physician : FPIN's Help Desk Answers
https://www.aafp.org/afp/2018/0401/od1.html
navigate_before 1 navigate_next